Literature DB >> 25444488

Severe sepsis and septic shock: clinical overview and update on management.

Kelly A Cawcutt1, Steve G Peters2.   

Abstract

Sepsis is among the oldest themes in medicine; however, despite modern advances, it remains a leading cause of death in the United States. Every clinician should be able to recognize the signs and symptoms of sepsis, along with early management strategies, to expeditiously provide appropriate care and decrease resultant morbidity and mortality. This review addresses the definitions, pathogenesis, clinical manifestations, management, and outcomes of patients with sepsis, severe sepsis, and septic shock.
Copyright © 2014 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25444488     DOI: 10.1016/j.mayocp.2014.07.009

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  26 in total

1.  Thrombocytopenia: A Risk Factor of Mortality for Patients with Sepsis in the Intensive Care Unit.

Authors:  Bünyamin Burunsuzoğlu; Cüneyt Saltürk; Zuhal Karakurt; Esra Akkütük Öngel; Huriye Berk Takır; Feyza Kargın; Gülbanu Horzum; Merih Balcı; Özlem Moçin; Nalan Adıgüzel; Gökay Güngör; Adnan Yılmaz
Journal:  Turk Thorac J       Date:  2015-12-14

2.  Sepsis in the era of data-driven medicine: personalizing risks, diagnoses, treatments and prognoses.

Authors:  Andrew C Liu; Krishna Patel; Ramya Dhatri Vunikili; Kipp W Johnson; Fahad Abdu; Shivani Kamath Belman; Benjamin S Glicksberg; Pratyush Tandale; Roberto Fontanez; Oommen K Mathew; Andrew Kasarskis; Priyabrata Mukherjee; Lakshminarayanan Subramanian; Joel T Dudley; Khader Shameer
Journal:  Brief Bioinform       Date:  2020-07-15       Impact factor: 11.622

3.  CYTL1 Promotes the Activation of Neutrophils in a Sepsis Model.

Authors:  Haiyan Xue; Shu Li; Xiujuan Zhao; Fuzheng Guo; Lilei Jiang; Yaxin Wang; Fengxue Zhu
Journal:  Inflammation       Date:  2020-02       Impact factor: 4.092

Review 4.  Bridging translation for acute kidney injury with better preclinical modeling of human disease.

Authors:  Nataliya I Skrypnyk; Leah J Siskind; Sarah Faubel; Mark P de Caestecker
Journal:  Am J Physiol Renal Physiol       Date:  2016-03-09

5.  The Severity of Acute Kidney and Lung Injuries Induced by Cecal Ligation and Puncture Is Attenuated by Menthol: Role of Proliferating Cell Nuclear Antigen and Apoptotic Markers.

Authors:  Aliaa Anter; Al-Shaimaa F Ahmed; Asmaa S A Hammad; Waleed Hassan Almalki; Sara Mohamed Naguib Abdel Hafez; AlShaimaa W Kasem; Mohamed A El-Moselhy; Mohammad W Alrabia; Ahmed R N Ibrahim; Mahmoud El-Daly
Journal:  Front Med (Lausanne)       Date:  2022-06-23

6.  The Association of Platelet Decrease Following Continuous Renal Replacement Therapy Initiation and Increased Rates of Secondary Infections.

Authors:  Benjamin R Griffin; Chaorong Wu; John C O'Horo; Sarah Faubel; Diana Jalal; Kianoush Kashani
Journal:  Crit Care Med       Date:  2021-02-01       Impact factor: 7.598

7.  lncRNA GAS5‑mediated miR‑23a‑3p promotes inflammation and cell apoptosis by targeting TLR4 in a cell model of sepsis.

Authors:  Zhenping Gao; Dan Huang
Journal:  Mol Med Rep       Date:  2021-05-13       Impact factor: 2.952

8.  Antibiotic regimens for early-onset neonatal sepsis.

Authors:  Steven Kwasi Korang; Sanam Safi; Chiara Nava; Adrienne Gordon; Munish Gupta; Gorm Greisen; Ulrik Lausten-Thomsen; Janus C Jakobsen
Journal:  Cochrane Database Syst Rev       Date:  2021-05-17

Review 9.  Activated Complement Factors as Disease Markers for Sepsis.

Authors:  Jean Charchaflieh; Julie Rushbrook; Samrat Worah; Ming Zhang
Journal:  Dis Markers       Date:  2015-09-02       Impact factor: 3.434

10.  The impairment of small nerve fibers in severe sepsis and septic shock.

Authors:  Hubertus Axer; Alexander Grimm; Christine Pausch; Ulrike Teschner; Jan Zinke; Sven Eisenach; Sindy Beck; Orlando Guntinas-Lichius; Frank M Brunkhorst; Otto W Witte
Journal:  Crit Care       Date:  2016-03-15       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.